CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Helsinn Healthcare S.A. v. Hospira Inc.

1:15-cv-00264

Overview

Case Number 1:15-cv-00264
Filing Date 2015-03-25
Status Terminated
Termination Date 2018-09-11
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hospira Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Helsinn Healthcare S.A. NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7947724
Liquid pharmaceutical formulations of palonosetron
Filed: 2005-07-21
Issued: 2011-05-24
Expired (Term Ended)
Expires: 2025-07-21
US7947725
Liquid pharmaceutical formulations of palonosetron
Filed: 2006-03-24
Issued: 2011-05-24
Expired (Term Ended)
Expires: 2026-03-24
US7960424
Liquid pharmaceutical formulations of palonosetron
Filed: 2006-03-24
Issued: 2011-06-14
Expired (Term Ended)
Expires: 2026-03-24
US8598219
Liquid pharmaceutical formulations of palonosetron
Filed: 2013-05-23
Issued: 2013-12-03
Active (6.5 yrs remaining)
Expires: 2033-05-23
US8729094
Liquid pharmaceutical formulations of palonosetron
Filed: 2013-05-24
Issued: 2014-05-20
Active (6.5 yrs remaining)
Expires: 2033-05-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

14

Dispositive

1

Granted

1

Denied

0

Pending / Review

13

Motions by Category

Procedural / Extension Motion 7 Motion to Stay 6 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER - 1. Plaintiffs' Motion to Stay (D.I. 19 ) is GRANTED; and 2. This matter is STAYED pending resolution of the Motion to Dismiss in the New Jersey action. ...
Entry #36 • 2016-02-19 Document →
Motion to Stay Pending / Under Review
[SEALED] REPLY BRIEF re 19 MOTION to Stay the Second-Filed Case in the District of Delaware filed by Helsinn Healthcare S.A., Roche Palo Alto LLC. (Jacobs, Kare...
Entry #30 • 2016-01-07 Document →
Motion to Stay Pending / Under Review
DECLARATION of Young J. Park re 30 Reply Brief, 19 Motion to Stay the Second-Filed Case in the District of Delaware by Helsinn Healthcare S.A., Roche Palo Alto ...
Entry #31 • 2016-01-07 Document →
Motion to Stay Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 19 MOTION to Stay the Second-Filed Case in the District of Delaware filed by Hospira Inc..Reply Brief due date per Loc...
Entry #25 • 2015-12-28 Document →
Motion to Stay Pending / Under Review
MOTION to Stay the Second-Filed Case in the District of Delaware - filed by Helsinn Healthcare S.A., Roche Palo Alto LLC. (Jacobs, Karen) Modified on 12/8/2015 ...
Entry #19 • 2015-12-07 Document →
Motion to Stay Pending / Under Review
[SEALED] OPENING BRIEF in Support re 19 MOTION to Stay the Second-Filed Case in the District of Delaware filed by Helsinn Healthcare S.A., Roche Palo Alto LLC. ...
Entry #20 • 2015-12-07 Document →

Docket Entries

(40 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Hospira Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1696890.) - filed by Roche Palo Alto LLC, Helsinn Healthcare S.A.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 03/26/2015)

Entry #1 • 2015-03-25
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 03/26/2015)

Entry #2 • 2015-03-25
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/11/2015. Date of Expiration of Patent: 01/30/2024.Thirty Month Stay Deadline: 8/11/2017. (dmp, ) (Entered: 03/26/2015)

Entry #3 • 2015-03-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,947,724 B2; 7,947,725 B2; 7,960,424 B2; 8,598,219 B2; 8,729,094 B2;. (dmp, ) (Entered: 03/26/2015)

Entry #4 • 2015-03-25
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Helsinn Holding S.A. for Helsinn Healthcare S.A. filed by Helsinn Healthcare S.A.. (dmp, ) (Entered: 03/26/2015)

Entry #5 • 2015-03-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc